Ligand validation:8IRB

HTG: heptyl 1-thio-beta-D-glucopyranoside

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8IRB_HTG_B_624	78%	42%	0.099	0.941	1.01	1.29	2	3	0	0	100%	1
8IRB_HTG_b_625	64%	35%	0.113	0.91	1.11	1.53	2	4	0	0	100%	1
8IRB_HTG_b_622	43%	25%	0.162	0.885	1.28	1.94	2	8	0	0	100%	1
8IRB_HTG_o_301	39%	32%	0.166	0.871	1.15	1.67	2	5	0	0	100%	1
8IRB_HTG_c_522	18%	41%	0.263	0.852	0.91	1.45	1	2	0	0	100%	1
8IRB_HTG_B_622	14%	44%	0.259	0.812	0.8	1.41	1	2	0	0	100%	1
8IRB_HTG_C_522	10%	43%	0.313	0.82	0.88	1.34	1	2	0	0	100%	1
8IRB_HTG_D_710	8%	37%	0.255	0.747	0.99	1.54	1	1	0	0	84%	0.8421
8IRB_HTG_d_409	7%	39%	0.323	0.803	0.97	1.49	1	1	0	0	84%	0.8421
8IRB_HTG_V_202	6%	58%	0.394	0.905	0.33	1.26	-	2	0	0	58%	0.5789
8IRB_HTG_b_623	1%	28%	0.468	0.693	1.09	1.91	1	2	0	0	100%	1
5V2C_HTG_O_303	94%	35%	0.072	0.972	1.58	1.07	2	2	0	0	100%	1
3WU2_HTG_O_303	89%	38%	0.092	0.971	1.17	1.32	2	1	0	0	100%	1
8IR7_HTG_b_625	81%	38%	0.086	0.939	0.97	1.5	2	3	0	0	100%	1
8IR6_HTG_b_625	81%	37%	0.088	0.941	1.07	1.48	2	4	0	0	100%	1
8IRA_HTG_B_625	81%	46%	0.097	0.95	0.97	1.12	2	2	0	0	100%	1
8IR9_HTG_B_623	81%	46%	0.098	0.95	0.99	1.13	2	3	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.